Skip to Content

REGISTER NOW TO BECOME A MEMBER

You are viewing the 1st of the 2 courses UPMC Physician Resources permits you to view without registering. To have full access to our FREE courses on our website, please register or log in now.
Register

In UPMC’s 2020 Update in Internal Medicine, Jaideep Behari, MD, PhD, provides background on Nonalcoholic Steatohepatitis (NASH) and presents new terminology. Dr. Behari also explains clinical challenges in medical management of NASH and identifies a practical framework for treatment. 

Educational Objectives 

Upon completion of this activity, participants should be able to: 

  • Identify and diagnose patients with Nonalcoholic Steatohepatitis (NASH)  using the new 2020 definition
  • Recall diagnostic skills for identifying patients at increased risk of NASH
  • Implement noninvasive testing for liver fibrosis in patients with fatty liver disease
  • Implement risk stratification in fatty liver patients by using the FIB-4 noninvastive test for liver fibrosis
  • Recognize recommendations to continue metformin and statin in patients with NASH

Disclosures

Dr. Behari has financial interests with the following entity or entities producing health care goods or services as indicated below:

  • Grant/Research Support: Endra Life Sciences, Pfizer, Gilead Sciences
  • Other: Institutional research grants from Intercept, Gilead, Galmed, Celgene, Allergan, Genentech

All presenters' disclosures of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers, and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh designates enduring material activity for a maximum of .75 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

For your credit transcript, please access our website four weeks postcompletion at http://ccehs.upmc.com and follow the link to the Credit Transcript page.

ABIM MOC Part 2 Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive your ABIM MOC Part 2 credit, you will need to complete the post-test with a pass rate of 100% and provide your date of birth and ABIM number, along with the other required fields.  This information will be shared with the American Board of Internal Medicine using the Accreditation Council for Continuing Medical Education Program and Activity Reporting System.

Release Date: 12/17/2020 | Last Modified On: 12/17/2020 | Expires: 12/17/2021

 

This course has been expired.